Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma
NCT ID: NCT03601689
Last Updated: 2018-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
84 participants
OBSERVATIONAL
2005-01-01
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rectal Sparing Approach After Preoperative Radio and/or Chemotherapy in Patients With Rectal Cancer
NCT02710812
Influence of Lengthening the Interval Between Radiochemotherapy and Surgery on Complete Pathological Response in Rectal Cancer
NCT01648894
Organ-preserving Management in Patients With Complete or Near-complete Tumour Response After Preoperative Radio(Chemo)Therapy for Rectal Cancer
NCT04095468
Radiotherapy & Total Neoadjuvant Therapy for Recurrent Rectal Cancer in Previously Irradiated Patients, an Italian Association for Radiotherapy and Clinical Oncology (AIRO)-GI Platform: a Multi-centre Prospective Observational Study
NCT05984576
Prognostic Factors Affecting Recurrence and Disease-Free Survival After Surgical Resection for Cancer Rectum
NCT06096493
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rectal resection
total mesorectal excision
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no previous or synchronous colorectal disease,
* UICC stage I-III patients who underwent neoadjuvant chemoradiotherapy or chemotherapy,
* followed by total mesorectal excision (TME), and
* a complete pathological response defined as ypT0N0
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Moroccan Society of Surgery
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Batna anticancer center
Algiers, , Algeria
Mohammed V University Medical School, Surgery Department, Military Hospital
Rabat, Please Enter the State Or Province, Morocco
Mohammed V University Medical School, Surgical Department "A", Ibn Sina Hospital
Rabat, Please Enter the State Or Province, Morocco
Mohammed V University Medical School, Surgical Department "C", Ibn Sina Hospital,
Rabat, Please Enter the State Or Province, Morocco
National Institut of Oncology, Surgical oncology department
Rabat, Please Enter the State Or Province, Morocco
Sidi Mohammed Ben Abdellah University Medical School, Surgery Department,
Fes, , Morocco
Mohammed Ist University Medical School, Surgical Oncology, Hospital el Farabi
Oujda, , Morocco
Private surgical oncology center
Salé, , Morocco
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Souadka A, Majbar MA, Benkabbou A, Serji B, Souiki T, Bouchentouf SM, Abid M, El Khannousi B, El Harroudi T, El Malki HO, Raiss M, Ifrine L, Mazaz K, Zentar A, Mohsine R, Souadka A, Belkouchi A, Ahallat M, Hrora A; Moroccan Society of Surgery. Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series. BMC Cancer. 2019 Oct 28;19(1):1008. doi: 10.1186/s12885-019-6239-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CompleteResponse
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.